A class action lawsuit against Seastar Medical Holding Corp. will proceed with Levi & Korsinsky as lead counsel.
On December 27, 2024, Federal Magistrate Judge Timothy O’Hara signed an order consolidating multiple lawsuits against Seastar into a single suit. The suits allege Seastar deceived investors about aspects of a merger, including an application to the FDA.
The Court found Levi & Korskinsky to be well-suited to lead this litigation, writing the firm is “is experienced in securities litigation an has been lead counsel in similar actions.” The Court appointed Raffi Khajerian as lead plaintiff.
A copy of the order can be found here.